Detalhe da pesquisa
1.
Tumor necrosis factor α promotes clonal dominance of KIT D816V+ cells in mastocytosis: role of survivin and impact on prognosis.
Blood
; 143(11): 1006-1017, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142424
2.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Mol Cancer
; 22(1): 133, 2023 08 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37573301
3.
Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Blood
; 137(2): 238-247, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777817
4.
The energy sensor AMPK orchestrates metabolic and translational adaptation in expanding T helper cells.
FASEB J
; 35(4): e21217, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715236
5.
Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis.
Haematologica
; 105(2): 366-374, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31018976
6.
Comparison of BCR-ABL1 quantification in peripheral blood and bone marrow using an International Scale-standardized assay for assessment of deep molecular response in chronic myeloid leukemia.
Clin Chem Lab Med
; 58(8): 1214-1222, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32084002
7.
CCL2 is a KIT D816V-dependent modulator of the bone marrow microenvironment in systemic mastocytosis.
Blood
; 129(3): 371-382, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27856463
8.
Digital PCR: A Sensitive and Precise Method for KIT D816V Quantification in Mastocytosis.
Clin Chem
; 64(3): 547-555, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29237714
9.
Mast cells are not associated with systemic insulin resistance.
Eur J Clin Invest
; 46(11): 911-919, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27600500
10.
CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells.
Cancers (Basel)
; 14(13)2022 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35804842
11.
PI3-kinase inhibition as a strategy to suppress the leukemic stem cell niche in Ph+ chronic myeloid leukemia.
Am J Cancer Res
; 11(12): 6042-6059, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35018241
12.
LMO3 reprograms visceral adipocyte metabolism during obesity.
J Mol Med (Berl)
; 99(8): 1151-1171, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34018016
13.
Microarray-Based Detection of Allergen-Reactive IgE in Patients with Mastocytosis.
J Allergy Clin Immunol Pract
; 8(8): 2761-2768.e16, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32348913
14.
A Multidisciplinary Intervention in Childhood Obesity Acutely Improves Insulin Resistance and Inflammatory Markers Independent From Body Composition.
Front Pediatr
; 8: 52, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32154197
15.
STAT5 is Expressed in CD34+/CD38- Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms.
Cancers (Basel)
; 12(4)2020 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326377
16.
CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T315I+ clones in TKI-resistant CML.
EBioMedicine
; 50: 111-121, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31761618
17.
Engraftment in NSGSCF mice correlates with the WHO category and prognosis in systemic mastocytosis.
Leukemia
; 37(5): 1162-1165, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918646
18.
Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation.
Sci Rep
; 7: 42191, 2017 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28169350
19.
Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis.
PLoS One
; 12(7): e0180900, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28742108
20.
The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation.
J Leukoc Biol
; 99(4): 583-94, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26497245